# Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer

> **NCT06499610** · PHASE4 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 44 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Irinotecan Hydrochloride Liposome Injection

## Key facts

- **NCT ID:** NCT06499610
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2027-10-15
- **Final completion:** 2027-10-15
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06499610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06499610, "Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06499610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*